Suji Jeong
Stock Analyst at Jefferies
(0.30)
# 4,417
Out of 4,425 analysts
5
Total ratings
33.33%
Success rate
-11%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SVRA Savara | Downgrades: Hold | $2 | $4.59 | -56.43% | 1 | Apr 3, 2023 | |
| INZY Inozyme Pharma | Upgrades: Buy | $4.5 → $6 | $4.51 | +33.04% | 2 | Mar 23, 2023 | |
| ANNX Annexon | Initiates: Buy | $12 | $4.87 | +146.41% | 1 | Sep 16, 2022 | |
| STOK Stoke Therapeutics | Initiates: Buy | $50 | $11.55 | +332.90% | 1 | Jan 31, 2022 |
Savara
Apr 3, 2023
Downgrades: Hold
Price Target: $2
Current: $4.59
Upside: -56.43%
Inozyme Pharma
Mar 23, 2023
Upgrades: Buy
Price Target: $4.5 → $6
Current: $4.51
Upside: +33.04%
Annexon
Sep 16, 2022
Initiates: Buy
Price Target: $12
Current: $4.87
Upside: +146.41%
Stoke Therapeutics
Jan 31, 2022
Initiates: Buy
Price Target: $50
Current: $11.55
Upside: +332.90%